Change Language

Himalaya Evecare Capsule

Himalaya Evecare Capsule

Product Details:

  • Drug Type General Medicines
  • Physical Form Capsules
  • Function Other
  • Dosage Guidelines As per prescription
  • Suitable For Women
  • Storage Instructions Cool and Dry Place
4.16 USD ($)
X

Himalaya Evecare Capsule Price And Quantity

  • 1 Box
  • 4.16 USD ($)

Himalaya Evecare Capsule Product Specifications

  • Capsules
  • General Medicines
  • As per prescription
  • Women
  • Cool and Dry Place
  • Other

Himalaya Evecare Capsule Trade Information

  • Cash in Advance (CID) Cheque
  • 1000 Box Per Day
  • 10 Days
  • bottle of 30 capsules
  • Australia Central America North America South America Eastern Europe Western Europe Middle East Africa Asia
  • All India

Product Description

Himalaya Evecare Capsule is a unique 4 power ingredient combination of Ashoka Tree (Ashoka), Asparagus (Shatavari), Lodh Tree (Lodhra) and Malabar Nut (Vasaka), which ensures complete uterine care. 
 
Role of Key Ingredients:

Ashoka Tree comes with estrogenic properties which heals the inner lining of the uterus during menstruation. 

Asparagus balances the hormonal level and regulates the menstrual cycle.

Lodh Tree improves fertility by regulating ovarian hormones.

Malabar Nut has anti-inflammatory and analgesic properties that provide relief from pain during dysmenorrhea (menstruation).
 
Himalaya Evecare Capsule is indicated for relief from premenstrual syndrome, dysfunctional uterine bleeding and assisted conception. The Himalaya Evecare Capsule is helpful in treating menstrual disorders like heavy bleeding, irregular periods and abdominal cramps. It can be consumed for increasing the level of hemoglobin, regulating reproductive function and also treating anemia due to uterine disorders. The Himalaya Evecare capsule is also recommended for general weakness in women.  
 
Use under Medical Supervision
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Women Care Medicines' category



We deal in bulk foreign inquiries.
Back to top